Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1987 1
2009 1
2012 1
2014 1
2015 3
2016 4
2017 5
2018 3
2019 2
2020 3
2021 5
2022 5
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
Postmarket policy considerations for biosimilar oncology drugs.
Renwick MJ, Smolina K, Gladstone EJ, Weymann D, Morgan SG. Renwick MJ, et al. Among authors: weymann d. Lancet Oncol. 2016 Jan;17(1):e31-8. doi: 10.1016/S1470-2045(15)00381-2. Epub 2015 Dec 23. Lancet Oncol. 2016. PMID: 26758759 Review.
Defining a Core Data Set for the Economic Evaluation of Precision Oncology.
Pollard S, Weymann D, Chan B, Ehman M, Wordsworth S, Buchanan J, Hanna TP, Ho C, Lim HJ, Lorgelly PK, Raymakers AJN, McCabe C, Regier DA. Pollard S, et al. Among authors: weymann d. Value Health. 2022 Aug;25(8):1371-1380. doi: 10.1016/j.jval.2022.01.005. Epub 2022 Feb 23. Value Health. 2022. PMID: 35216902 Free article. Review.
Whole-genome and transcriptome analysis enhances precision cancer treatment options.
Pleasance E, Bohm A, Williamson LM, Nelson JMT, Shen Y, Bonakdar M, Titmuss E, Csizmok V, Wee K, Hosseinzadeh S, Grisdale CJ, Reisle C, Taylor GA, Lewis E, Jones MR, Bleile D, Sadeghi S, Zhang W, Davies A, Pellegrini B, Wong T, Bowlby R, Chan SK, Mungall KL, Chuah E, Mungall AJ, Moore RA, Zhao Y, Deol B, Fisic A, Fok A, Regier DA, Weymann D, Schaeffer DF, Young S, Yip S, Schrader K, Levasseur N, Taylor SK, Feng X, Tinker A, Savage KJ, Chia S, Gelmon K, Sun S, Lim H, Renouf DJ, Jones SJM, Marra MA, Laskin J. Pleasance E, et al. Among authors: weymann d. Ann Oncol. 2022 Sep;33(9):939-949. doi: 10.1016/j.annonc.2022.05.522. Epub 2022 Jun 9. Ann Oncol. 2022. PMID: 35691590 Free article.
Impact on costs and outcomes of multi-gene panel testing for advanced solid malignancies: a cost-consequence analysis using linked administrative data.
Hernando-Calvo A, Nguyen P, Bedard PL, Chan KKW, Saleh RR, Weymann D, Yu C, Amir E, Regier DA, Gyawali B, Kain D, Wilson B, Earle CC, Mittmann N, Abdul Razak AR, Isaranuwatchai W, Sabatini P, Spreafico A, Stockley TL, Pugh TJ, Williams C, Siu LL, Hanna TP. Hernando-Calvo A, et al. Among authors: weymann d. EClinicalMedicine. 2024 Feb 12;69:102443. doi: 10.1016/j.eclinm.2024.102443. eCollection 2024 Mar. EClinicalMedicine. 2024. PMID: 38380071 Free PMC article.
35 results